Transgender and Gender-Diverse Patient Perspectives on Hereditary Breast Cancer Risk Assessment in Gender-Affirming Top Surgeries
From these themes, we derived actionable guidance to address breast cancer health equity in this population. Enhancing patient education, increasing provider awareness, and developing inclusive clinical practice guidelines are crucial steps in effectively addressing breast cancer risk in individuals receiving surgery. It is vital to degender health spaces to promote inclusion and accessibility of breast cancer prevention. Integrating genetics professionals and cancer risk assessment into transgender health clinics and the top surgery process is paramount for delivering personalized care and facilitating informed surgical decision making.
Authors
- Kimberly Zayhowski (ORCID: https://orcid.org/0000-0003-1712-6403)
- Tala Berro (ORCID: https://orcid.org/0000-0001-8541-6336)
- Carl G. Streed (ORCID: https://orcid.org/0000-0003-3075-253X)
- Ian M. MacFarlane
- Kathleen F. Mittendorf (ORCID: https://orcid.org/0000-0003-1097-9171)
- Kai Blumen
Institutions
- Boston University (US)
- Boston Medical Center (US)
- University of Minnesota (US)
- Kaiser Permanente (US)
- Spectrum Health (US)
- Kaiser Permanente Oakland Medical Center (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1200/po-25-00037
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00